- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04046718
Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients
August 4, 2021 updated by: Ramy Salama Draz
Lipid Profile Response to Electroacupuncture
sixty female patients suffering from non-alcoholic fatty liver disease were randomly divided into two equal groups group 1 received electroacupuncture stimulation for 6 weeks at special points of stimulation.
group 2 was a control group that received nothing without any change in lifestyle and we assed the response of lipid profile post-treatment protocol in both groupes
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- Faculty of Physical Therapy Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
non alcoholic fatty liver BMI 30-40
Exclusion Criteria:
- Patients with: (Hepatitis C & b any form of seizure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: electroacupuncture
the study group received electroacupuncture stimulation at different points
|
stimulation of acupoints of the liver meridian of lv3 lv14
|
|
No Intervention: control group
a control group with no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
tri-triglycerides (mg/dl) , total cholesterol (mg/dl) , HDL (mg/dl) , LDL (mg/dl)
Time Frame: 6 weeks
|
lowering of total lipid profile in study group
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight (kg) , height (m), BMI (kg/m2)
Time Frame: 1st week
|
calculation of body mass index
|
1st week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 22, 2019
Primary Completion (Actual)
November 25, 2019
Study Completion (Actual)
December 29, 2019
Study Registration Dates
First Submitted
August 3, 2019
First Submitted That Met QC Criteria
August 3, 2019
First Posted (Actual)
August 6, 2019
Study Record Updates
Last Update Posted (Actual)
August 6, 2021
Last Update Submitted That Met QC Criteria
August 4, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/001579_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatty Liver , Electroacupuncture, Lipid Profile
-
University of LahoreRecruitingLipid Profile | Liver BiomarkersPakistan
-
University of LahoreCompletedLipid Profile | Hypertension (HTN) | Liver EnzymesPakistan
-
Shaheed Benazir Bhutto University Sheringal Dir...Khyber Medical University PeshawarNot yet recruitingLipid Profile,Blood PressurePakistan
-
Sheba Medical CenterCompletedLipid Profile in PregnancyIsrael
-
University of TorontoActive, not recruitingCardiovascular Diseases | Lipid Disorder | Non-Alcoholic Fatty Liver Disease | Metabolic DiseaseCanada
-
Mayo ClinicRecruitingBlood Pressure | Lipid Profile | Fasting GlucoseUnited States
-
Eli Lilly and CompanyTerminatedDyslipidemias | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Shahid Beheshti UniversityCompleted
-
OrsoBio, IncRecruitingHypertriglyceridemia | Nonalcoholic Fatty Liver DiseaseMexico
Clinical Trials on electro-acupuncture stimulation
-
McMaster UniversityHolistic Health Research Foundation of Canada; Canadian Interdisciplinary Network...Withdrawn
-
Nova Southeastern UniversityNational Eye Institute (NEI)Active, not recruitingRetinitis PigmentosaUnited States
-
Hubei Hospital of Traditional Chinese MedicineCompletedObesity, AbdominalChina
-
China Academy of Chinese Medical SciencesUnknownImpaired Glucose Tolerance
-
Guang'anmen Hospital of China Academy of Chinese...Ministry of Science and Technology of the People´s Republic of ChinaCompleted
-
Chengdu University of Traditional Chinese MedicineCompleted
-
University of SkövdeCompleted
-
University of California, IrvineRecruiting
-
Egyptian Chinese UniversityCompleted
-
National Heart Centre SingaporeCompletedCoronary Artery Disease | Electro-AcupunctureSingapore